Episode 874
TWiV 874: COVID-19 clinical update #105 with Dr. Daniel Griffin
March 12, 202240m 39s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #105, Daniel Griffin discusses changes in brain structure after infection, dementia in patients with pneumonia, Paxlovid in children, mask effectiveness in schools, host factors and severe disease, post-acute symptoms, and the mission of CEPI.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Infection and changes in brain structure (Nature)
- Dementia among pneumonia survivors (Open Forum Inf Dis)
- Narrative dynamics around COVID-19 vaccines (FSI)
- Children and COVID (AAP)
- Paxlovid in pediatric patients (Pfizer)
- Mask effectiveness in schools (MMWR)
- Host factors and severe disease (Nature)
- Antiviral efficacy against BA.2 (NEJM)
- Post-acute symptoms, Denmark (medRxiv)
- Risk of sequelae after infection (BMJ)
- CEPI (TWiV 612)
- Contribute to ASTMH fundraiser at PWB
- Letters read on TWiV 874
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]